Belgium· BE-AMP-SAM552080-00
Ervebo
A ebola-impfstoffe product containing ebola zaire vaccine (rvsvδg-zebov-gp), live, attenuated; recombinant vesicular stomatitis virus (rvsv) strain indiana with a deletion of the vsv envelope glycoprotein (g) replaced with the zaire ebola virus (zebov) kikwit 1995 strain surface glycoprotein, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ebola-impfstoffe is registered in 9 of 19 countries.
Countries holding a registration under ATC J07BX02 (ebola-impfstoffe), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Ebola-impfstoffe · ATC J07BX02
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP), live, attenuated; Recombinant Vesicular Stomatitis Virus (rVSV) strain Indiana with a deletion of the VSV envelope glycoprotein (G) replaced with the Zaire Ebola Virus (ZEBOV) Kikwit 1995 strain surface glycoprotein
- Manufacturer
- Merck Sharp & Dohme
- Country
- Belgium (BE)
- ATC code
- J07BX02
- ATC class
- Ebola-Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX02
Ebola-impfstoffe, as other registers publish it.
- FinlandErveboMerck Sharp & Dohme B.V.
- DenmarkErveboMerck Sharp & Dohme B.V.
- IcelandErveboMerck Sharp & Dohme B.V.*
- PolandErveboMerck Sharp & Dohme B.V.
- CzechiaERVEBOMerck Sharp & Dohme B.V., Haarlem
- IrelandErvebo solution for injectionMerck Sharp & Dohme BV,
- SwitzerlandErvebo, InjektionslösungMSD Merck Sharp & Dohme AG
- NetherlandsErvebo, oplossing voor injectieMerck Sharp & Dohme B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a8add598-7a95-42b7-96f5-125199b8a124 GET /v1/drugs/a8add598-7a95-42b7-96f5-125199b8a124?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Ervebo",
"name_fr": "Ervebo",
"name_nl": "Ervebo",
"amp_code": "SAM552080-00",
"strengths": null,
"pack_count": 1,
"substances": [
"Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP), live, attenuated; Recombinant Vesicular Stomatitis Virus (rVSV) strain Indiana with a deletion of the VSV envelope glycoprotein (G) replaced with the Zaire Ebola Virus (ZEBOV) Kikwit 1995 strain surface glycoprotein",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ebola Vaccines",
"authorisation_numbers": [
"EU/1/19/1392/001"
]
}See everything about ebola-impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.